Test trial suggests hallucinogenic concoction ayahuasca provides relief from depression

April 19, 2017 by Bob Yirka report
Ayahuasca being prepared in the Napo region of Ecuador. Credit: Wikipedia

(Medical Xpress)—A team of researchers from several institutions in Spain and Brazil has conducted test trials of a South American concoction known as ayahuasca to learn more about its impact on people suffering from depression. In their paper uploaded to bioRxiv the team describes the trials they conducted and what they found.

Two years ago, the same team conducted some initial tests to find out if ayahuasca reduced symptoms of depression—they reported back then that the results were promising. Seeking to expand on their work, the researchers undertook another test trial, this time enlisting the assistance of 39 volunteers, 14 of whom actually consumed the concoction, while the other 15 were given a placebo.

Ayahuasca has been known in South America for centuries, it is a beverage made by brewing two types of vines, Psychotria viridis, which contains a hallucinogenic compound, and Banisteriopsis caapi, which prevents the mind-altering compound from being broken down before it has time to pass from the gut to the brain. The result is a brew that by all accounts tastes quite nasty, and in some cases causes people to vomit. But it also induces a mind-bending experience. Anecdotal evidence has also suggested that it can improve symptoms for people suffering from depression, which led to the first and now second trial.

Each of the volunteers suffered from , and each was asked to fill out a questionnaire regarding their mood the day before being given a single dose of ayahuasca (or an equally nasty-tasting concoction created as a placebo). On the day of dosing, each was given a small amount of ayahuasca or the placebo, and were kept in a safe room for four hours, which was how long it takes for the effects to subside. Each of the volunteers were then asked to again fill out the same questionnaire a day later, then two days later, and then a week after the trial.

The researchers report that both groups reported relief from symptoms one and two days after the trial, which is common for drug . But after a week, 64 percent of those given ayahuasca reported a reduction in symptoms of approximately 50 percent, compared to just 27 percent for those given a .

Explore further: Substance present in ayahuasca brew stimulates generation of human neural cells

More information: Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomised placebo-controlled trial, bioRxiv, biorxiv.org/content/early/2017/01/27/103531

Abstract
Major Depressive Disorder affects about 350 million people worldwide, and about one-third of the patients are considered treatment-resistant. Furthermore, available antidepressants take usually two weeks for the onset of their antidepressant effect. Recent open label trials show that psychedelics, such as ayahuasca and psilocybin, hold promise as fast-onset antidepressants. Although promising, these studies were not controlled for the placebo effect. To address this issue, and to further test the antidepressant effects of ayahuasca, we conducted a parallel arm, double blind randomised placebo-controlled trial, in patients with treatment-resistant major depression. Thirty-five patients with treatment-resistant major depression received a single dose of ayahuasca or placebo. We measured as primary outcome the change in the Hamilton Depression Rating scale (HAM-D) seven days after the dosing session, and as secondary outcomes the changes in Montgomery-Asberg Depression Rating Scale (MADRS), and response rates at one day (D1), two days (D2) and seven days (D7) after dosing, and remission rates at D7. This study is registered with clinicaltrials.gov (NCT02914769). We observed robust evidence of rapid antidepressant effects of a single dosing session with ayahuasca when compared to placebo. HAM-D scores at D7 were significantly lower in patients treated with ayahuasca than in those treated with placebo (p=0.019; Cohen's d=0.98). MADRS scores were significantly reduced in the ayahuasca group compared to the placebo group at all endpoints (at D1 and D2, p=0.04; at D7, p<0.0001). Between-group effect sizes increased from D1 to D7 (D1: Cohen's d=0.84; D2: Cohen's d=0.84; D7: Cohen's d=1.49). Response rates were high for both groups at D1 and D2, and were significantly higher in the ayahuasca group only at D7 (64% vs. 27%; OR = 4.95; p = 0.04; NNT = 2.66). Remission rate was not significantly different between groups. Our study provides new evidence of rapid antidepressant effects of ayahuasca for treatment-resistant major depression.

Related Stories

Substance present in ayahuasca brew stimulates generation of human neural cells

December 7, 2016
Ayahuasca is a beverage that has been used for centuries by Native South-Americans. Studies suggest that it exhibits anxiolytic and antidepressant effects in humans. One of the main substances present in the beverage is harmine, ...

Antidepressant efficacy varies for depressive symptom clusters

February 28, 2017
(HealthDay)—Antidepressant treatment efficacy varies for empirically-defined clusters of symptoms, according to a study published online Feb. 22 in JAMA Psychiatry.

Brain architecture alters to compensate for depression

March 7, 2017
A study led by Ravi Bansal, PhD, and Bradley S. Peterson, MD, of The Saban Research Institute of Children's Hospital Los Angeles, has found structural differences in the cerebral cortex of patients with depression and that ...

Study results suggest improving posture may help reduce depression

February 6, 2017
(Medical Xpress)—A team of researchers at the University of Auckland has found evidence that suggests people who are depressed can improve their outlook simply by modifying their posture while sitting. In their paper published ...

Larger doses of vitamin C may lead to a greater reduction in common cold duration

March 30, 2017
The relationship between vitamin C dosage and its effects on the duration of the common cold symptoms may extend to 6-8 grams per day.

Depression drug reduces joint pain for women with early stage breast cancer

December 9, 2016
A drug typically used to treat depression and anxiety can significantly reduce joint pain in postmenopausal women being treated for early stage breast cancer, according to new SWOG research to be presented Friday at a special ...

Recommended for you

Depression changes structure of the brain, study suggests

July 21, 2017
Changes in the brain's structure that could be the result of depression have been identified in a major scanning study.

Many kinds of happiness promote better health, study finds

July 21, 2017
A new study links the capacity to feel a variety of upbeat emotions to better health.

Study examines effects of stopping psychiatric medication

July 20, 2017
Despite numerous obstacles and severe withdrawal effects, long-term users of psychiatric drugs can stop taking them if they choose, and mental health care professionals could be more helpful to such individuals, according ...

Study finds gene variant increases risk for depression

July 20, 2017
A University of Central Florida study has found that a gene variant, thought to be carried by nearly 25 percent of the population, increases the odds of developing depression.

In making decisions, are you an ant or a grasshopper?

July 20, 2017
In one of Aesop's famous fables, we are introduced to the grasshopper and the ant, whose decisions about how to spend their time affect their lives and future. The jovial grasshopper has a blast all summer singing and playing, ...

Perceiving oneself as less physically active than peers is linked to a shorter lifespan

July 20, 2017
Would you say that you are physically more active, less active, or about equally active as other people your age?

4 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

Munix
not rated yet Apr 19, 2017
Of course this concoction is going to take away someone's depression. (And any other problem you may have.)

Why? Because you are stoned out of your freakin mind for hours!
richdiggins
not rated yet Apr 19, 2017
Here is first hand experience with ayahusca.
https://www.swear...isodes/1

I have read other reports on this site regarding magic mushrooms being used to treat depression, as well. Perhaps there is more than just being high, perhaps there is something chemical going on in the brain.
EmceeSquared
1 / 5 (3) Apr 19, 2017
They were stoned out of their freakin mind for 4 hours. Their depression was reduced by half even *after a week*, as the article clearly says. Meanwhile, other commercial depression medications must be taken daily or more frequently, and many don't have such strong effects on so many subjects.

If only getting stoned could cure people of their Dunning Kruger disease.

Munix:
Of course

EmceeSquared
1 / 5 (3) Apr 19, 2017
Well, being high is something chemical going on in the brain. The brain is a mass of chemicals; every mental experience and process is something chemical going on in there. Being high is our perception of the unusual chemistry going on in the brain.

And indeed other researchers have found that "just being high" on LSD, psilocybin and ketamine is a distinct state of mathematically describable "higher consciousness" in the brain:

"First evidence for higher state of consciousness found"
https://medicalxp...nsciousn
ess.html

richdiggins:
perhaps there is something chemical going on in the brain.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.